News & Updates

Secukinumab gets FDA nod for nr-axSpA

05 Aug 2020 by

The US FDA has given secukinumab the greenlight for the treatment of active non-radiographic axial spondyloarthritis (nr-axSpA), following its success in the phase III PREVENT trial, the largest ever for a biologic in nr-axSpa.

Secukinumab gets FDA nod for nr-axSpA

05 Aug 2020

Novel biomarkers of disease activity identified in various forms of vasculitis

04 Aug 2020

Several serum biomarkers of disease activity have been recognized in giant cell arteritis (GCA) and eosinophilic granulomatosis with polyangiitis (EGPA), according to a study. Moreover, differences in biomarker levels between diseases are more evident than those related to disease activity.

Novel biomarkers of disease activity identified in various forms of vasculitis

04 Aug 2020

$Tofacitinib, peficitinib touted as top treatments for refractory RA$

Tofacitinib, peficitinib touted as top treatments for refractory RA

04 Aug 2020 by

The Janus kinase inhibitors tofacitinib 10 mg and peficitinib 150 mg prove to be the most effective regimens in the treatment of patients with refractory rheumatoid arthritis (RA) receiving methotrexate (MTX), without increasing the risk of serious adverse events, according to the results of a network meta-analysis.

Tofacitinib, peficitinib touted as top treatments for refractory RA

04 Aug 2020

Brain stimulation relieves pain in fibromyalgia patients

31 Jul 2020

Extended treatment with transcranial direct current stimulation applied over dorsolateral prefrontal cortex induces large reductions in pain in fibromyalgia patients, as shown in a study.

Brain stimulation relieves pain in fibromyalgia patients

31 Jul 2020

$Sequential therapy with abaloparatide, alendronate cuts fracture risk in older women$

Sequential therapy with abaloparatide, alendronate cuts fracture risk in older women

30 Jul 2020

A strategy of administering abaloparatide for 18 months followed by 24 months of alendronate holds fracture risk at bay in older postmenopausal women with osteoporosis, as shown in a study.

Sequential therapy with abaloparatide, alendronate cuts fracture risk in older women

30 Jul 2020

Mineral bath, mud therapy may improve symptoms, function in knee OA patients

29 Jul 2020 by

Balneotherapy and peloid therapy demonstrated efficacy in reducing pain and improving function in patients with knee osteoarthritis (OA) as opposed to physical therapy (PT) alone, a study has shown.

Mineral bath, mud therapy may improve symptoms, function in knee OA patients

29 Jul 2020

Final SPIRIT-H2H data still favour ixekizumab for biologic-naïve PsA patients

28 Jul 2020 by

The final 1-year results from the SPIRIT-H2H* trial have shown that ixekizumab remains superior to adalimumab for treating biologic-naïve patients with psoriatic arthritis (PsA).

Final SPIRIT-H2H data still favour ixekizumab for biologic-naïve PsA patients

28 Jul 2020

Canakinumab delivers rapid, durable benefits in systemic juvenile idiopathic arthritis

28 Jul 2020

Treatment with canakinumab produces improvements in systemic juvenile idiopathic arthritis (sJIA), which occur shortly after initiation and last up to 6 months, according to the results of an open‐label, active treatment extension study.

Canakinumab delivers rapid, durable benefits in systemic juvenile idiopathic arthritis

28 Jul 2020

Add-on curcuminoid complex a treatment alternative for knee OA?

27 Jul 2020 by

Adding curcuminoid complex (CC)* to diclofenac led to greater improvements in pain and functional capacity with better tolerability in individuals with knee osteoarthritis (OA), an Indian study has shown, highlighting the potential of CC as an alternative for knee OA management.

Add-on curcuminoid complex a treatment alternative for knee OA?

27 Jul 2020

Anakinra shows promise in gout treatment

21 Jul 2020 by

The IL-1 receptor antagonist anakinra – a drug for rheumatoid arthritis – demonstrated potential in treating gout, as it reduced gout pain and flares to similar degrees as triamcinolone, results of the ANAGO* study have shown.

Anakinra shows promise in gout treatment

21 Jul 2020

News & Updates

Filter by Specialty:

Specialty:

Secukinumab gets FDA nod for nr-axSpA

Secukinumab gets FDA nod for nr-axSpA

Novel biomarkers of disease activity identified in various forms of vasculitis

Novel biomarkers of disease activity identified in various forms of vasculitis

Tofacitinib, peficitinib touted as top treatments for refractory RA

Tofacitinib, peficitinib touted as top treatments for refractory RA

Brain stimulation relieves pain in fibromyalgia patients

Brain stimulation relieves pain in fibromyalgia patients

Sequential therapy with abaloparatide, alendronate cuts fracture risk in older women

Sequential therapy with abaloparatide, alendronate cuts fracture risk in older women

Mineral bath, mud therapy may improve symptoms, function in knee OA patients

Mineral bath, mud therapy may improve symptoms, function in knee OA patients

Final SPIRIT-H2H data still favour ixekizumab for biologic-naïve PsA patients

Final SPIRIT-H2H data still favour ixekizumab for biologic-naïve PsA patients

Canakinumab delivers rapid, durable benefits in systemic juvenile idiopathic arthritis

Canakinumab delivers rapid, durable benefits in systemic juvenile idiopathic arthritis

Add-on curcuminoid complex a treatment alternative for knee OA?

Add-on curcuminoid complex a treatment alternative for knee OA?

Anakinra shows promise in gout treatment

Anakinra shows promise in gout treatment